EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

EGX:NIPH Revenue

EI- Nile Co. for Pharmaceuticals and Chemical Industries had revenue of 681.20M EGP in the quarter ending September 30, 2025, with 459.42% growth. This brings the company's revenue in the last twelve months to 1.85B, up 108.78% year-over-year. In the fiscal year ending June 30, 2025, EI- Nile Co. for Pharmaceuticals and Chemical Industries had annual revenue of 1.29B with 12.86% growth.

• Revenue (ttm): 1.85B
• Revenue Growth: +108.78%
• P/S Ratio: 1.51
• Revenue / Employee: 739.60K
• Employees: 2,500
• Market Cap: 2.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.29B	146.99M	12.86%
Jun 30, 2024	1.14B	137.37M	13.67%
Jun 30, 2023	1.01B	128.44M	14.65%
Jun 30, 2022	876.78M	121.27M	16.05%
Jun 30, 2021	755.51M	-57.02M	-7.02%